Showing results (1-10 of 7) with videos related to
Sort By:
Pageof 1
Methods in Molecular Biology (Clifton, N.J.)|August 22, 2020
Analysis of 5-Hydroxymethyluracil Levels Using Flow CytometryLidia Gackowska, Anna Labejszo, Daniel GackowskiPlos One|April 10, 2018
Correction: Profiles of a broad spectrum of epigenetic DNA modifications in normal and malignant human cell lines: Proliferation rate is not the major factor responsible for the 5-hydroxymethyl-2'-deoxycytidine level in cultured cancerous cell linesMarek Foksinski, Ewelina Zarakowska, Daniel Gackowski, et al.Plos One|December 1, 2017
Profiles of a broad spectrum of epigenetic DNA modifications in normal and malignant human cell lines: Proliferation rate is not the major factor responsible for the 5-hydroxymethyl-2'-deoxycytidine level in cultured cancerous cell linesMarek Foksinski, Ewelina Zarakowska, Daniel Gackowski, et al.Journal of Translational Medicine|July 22, 2018
In vivo evidence of ascorbate involvement in the generation of epigenetic DNA modifications in leukocytes from patients with colorectal carcinoma, benign adenoma and inflammatory bowel diseaseMarta Starczak, Ewelina Zarakowska, Martyna Modrzejewska, et al.Clinical Epigenetics|June 8, 2018
Characteristic profiles of DNA epigenetic modifications in colon cancer and its predisposing conditions-benign adenomas and inflammatory bowel diseaseTomasz Dziaman, Daniel Gackowski, Jolanta Guz, et al.Cells|March 10, 2022
Diagnostic and Prognostic Power of Active DNA Demethylation Pathway Intermediates in Acute Myelogenous Leukemia and Myelodysplastic SyndromesAleksandra Skalska-Bugala, Marta Starczak, Łukasz Szukalski, et al.Scientific Reports|November 2, 2021
The urinary excretion of epigenetically modified DNA as a marker of pediatric ALL status and chemotherapy responseRafal Rozalski, Daniel Gackowski, Aleksandra Skalska-Bugala, et al.Pageof 1